Ignite Creation Date:
2024-05-06 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 2:31 PM
Study NCT ID:
NCT05346224
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-16
First Post:
2022-04-17
Brief Title:
A Study to Evaluate the Efficacy and Safety of HLX11 vs EU-Perjeta in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer
Sponsor:
Organization:
Shanghai Henlius Biotech